In breast cancer, increased expression of SDC1 on the cell surface was associated with reduced overall survival in ER‐ cells, while higher levels of stromal SDC1 indicate poor survival prognosis for patients with ER+ cancer. This evidence concerns the gene SDC1 and cancer.